Clinical Trials Directory

Trials / Conditions / Stage IV Prostate Cancer AJCC v7

Stage IV Prostate Cancer AJCC v7

15 registered clinical trials studyying Stage IV Prostate Cancer AJCC v7 — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069
Alliance for Clinical Trials in Oncology—
RecruitingStudy to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therap
NCT04775355
City of Hope Medical Center—
CompletedFatigue Interventions in Cancer (Exercise Intervention)
NCT03421782
University of UtahPhase 2
CompletedGallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer
NCT03448458
Emory UniversityPhase 2
CompletedA Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Me
NCT02849990
University of WashingtonPhase 2
Completed68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
NCT03368547
Jonsson Comprehensive Cancer CenterN/A
TerminatedSirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cance
NCT02565901
University of WashingtonPhase 1 / Phase 2
CompletedEnzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prost
NCT02555189
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 1 / Phase 2
Active Not RecruitingEnzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer
NCT02522715
OHSU Knight Cancer InstitutePhase 1 / Phase 2
CompletedRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfun
NCT01638533
National Cancer Institute (NCI)Phase 1
CompletedAbiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-R
NCT01576172
National Cancer Institute (NCI)Phase 2
Active Not RecruitingAkt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostat
NCT01480154
National Cancer Institute (NCI)Phase 1
RecruitingCollecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate o
NCT01050504
University of Washington—
CompletedGemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary
NCT00942331
National Cancer Institute (NCI)Phase 3
CompletedIpilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer
NCT00064129
National Cancer Institute (NCI)Phase 1